Charlotte L B M Korst

7PUBLICATIONS
20CO-AUTHORS
Medical mycologyMolecular targetsPharmacogenomicsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 20, 2026
Monocyte-mediated metabolic rewiring via CD31-CD38 interactions promotes growth and drug-resistance in multiple myeloma.

|Nov 27, 2025
Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network.

Niels W C J van de Donk, Philippe Moreau, Jesus F San-Miguel

|Nov 03, 2025
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma.

M R Seefat, D G J Cucchi, L van Boven

|Oct 07, 2025
Immune signatures in older patients with newly diagnosed multiple myeloma are associated with survival outcomes of first-line therapy irrespective of frailty levels.

Wassilis S C Bruins, Febe Smits, Carolien Duetz

|Aug 19, 2025
A T-cell-based metric of immune age predicts outcomes in older patients with myeloma receiving daratumumab-based therapy.

Wassilis S C Bruins, Febe Smits, Carolien Duetz

|Jul 26, 2024
Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma.

Charlotte L B M Korst, Chloe O'Neill, Wassilis S C Bruins

Pageof 2

Frequent Collaborators

4 joint publications

Niels W C J van de Donk

3 joint publications

Wassilis S C Bruins

2 joint publications

Tuna Mutis

2 joint publications

Kazimierz Groen